Risk of Venous Thromboembolism in Pregnant Women with Essential Thrombocythemia: A Systematic Review and Meta-Analysis

In women with essential thrombocythemia, the absolute risk of a venous thromboembolism in the postpartum period is above a threshold where postpartum low-molecular-weight heparin prophylaxis should be considered. The absolute risk of venous thromboembolism in the antepartum period is not above a threshold where antepartum low-molecular-weight heparin is clearly indicated or below a threshold where low-molecular-weight heparin should be withheld. Thus, a preferences and values-based discussion is important when counseling women with essential thrombocythemia in pregnancy.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.